Cargando…

Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study

PURPOSE: To evaluate the relationship between macular pigment optical density (MPOD) and glaucoma. METHODS: Forty-three patients with an established glaucoma diagnosis (25 females, 18 males, mean age 70 (range 34–84)) and 43 healthy controls (28 females, 15 males, mean age 62 (range 30–87)) were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruns, Yannick, Junker, Bernd, Boehringer, Daniel, Framme, Carsten, Pielen, Amelie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140904/
https://www.ncbi.nlm.nih.gov/pubmed/32308361
http://dx.doi.org/10.2147/OPTH.S224259
_version_ 1783519095987109888
author Bruns, Yannick
Junker, Bernd
Boehringer, Daniel
Framme, Carsten
Pielen, Amelie
author_facet Bruns, Yannick
Junker, Bernd
Boehringer, Daniel
Framme, Carsten
Pielen, Amelie
author_sort Bruns, Yannick
collection PubMed
description PURPOSE: To evaluate the relationship between macular pigment optical density (MPOD) and glaucoma. METHODS: Forty-three patients with an established glaucoma diagnosis (25 females, 18 males, mean age 70 (range 34–84)) and 43 healthy controls (28 females, 15 males, mean age 62 (range 30–87)) were included in this prospective diagnostic case-control study. All subjects underwent detailed eye examination including ophthalmoscopy, best-corrected visual acuity, biomicroscopy, measurement of the axial length of the eye, objective refraction, lens status, central foveal thickness on spectral-domain optical coherence tomography (SD-OCT). In all glaucoma patients, a visual field assessment and a measurement of the retinal nerve fibre layer (RNFL) on SD-OCT were done. MPOD was determined using the macula pigment module of the Spectralis HRA+OCT (Heidelberg Engineering GmbH, Heidelberg, Germany) at 0.51°, 1.02° and 1.99° retinal eccentricity using two-wavelength autofluorescence imaging. RESULTS: In the glaucoma group, the median of the visual field mean defect was 5.1 db (quartiles 3.0 and 13.5) and the mean RNFL-thickness global was 65.9 µm (SD ± 16.1). Median MPOD measured at 0.51°, 1.02° and 1.99° retinal eccentricity in the glaucoma group was 0.42 DU, 0.34 DU and 0.13 DU, in the control group 0.40 DU, 0.35 DU and 0.12 DU respectively. There was no statistically significant difference of median MPOD between glaucomatous and control eyes (p=0.510, 0.735, 0.481). No significant relation between MPOD at 1.02 retinal eccentricity and the presence of glare symptoms was found (p=0.948). However, age seems to correlate with median MPOD measured at 1.02 retinal eccentricity (p=0.017). CONCLUSION: There was no evidence for lower MPOD levels in our glaucoma patients; lower MPOD was not related to the presence of glare symptoms. However there seems to be a positive correlation between age and MPOD at 1.02° retinal eccentricity. To further investigate the relation between glare reported by glaucoma patients and glare disability linked to lower MPOD levels, additional studies are necessary that include both detailed inquiry of the quality of glare and a glare quantification and precise analysis of MPOD levels in glaucoma patients.
format Online
Article
Text
id pubmed-7140904
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-71409042020-04-17 Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study Bruns, Yannick Junker, Bernd Boehringer, Daniel Framme, Carsten Pielen, Amelie Clin Ophthalmol Original Research PURPOSE: To evaluate the relationship between macular pigment optical density (MPOD) and glaucoma. METHODS: Forty-three patients with an established glaucoma diagnosis (25 females, 18 males, mean age 70 (range 34–84)) and 43 healthy controls (28 females, 15 males, mean age 62 (range 30–87)) were included in this prospective diagnostic case-control study. All subjects underwent detailed eye examination including ophthalmoscopy, best-corrected visual acuity, biomicroscopy, measurement of the axial length of the eye, objective refraction, lens status, central foveal thickness on spectral-domain optical coherence tomography (SD-OCT). In all glaucoma patients, a visual field assessment and a measurement of the retinal nerve fibre layer (RNFL) on SD-OCT were done. MPOD was determined using the macula pigment module of the Spectralis HRA+OCT (Heidelberg Engineering GmbH, Heidelberg, Germany) at 0.51°, 1.02° and 1.99° retinal eccentricity using two-wavelength autofluorescence imaging. RESULTS: In the glaucoma group, the median of the visual field mean defect was 5.1 db (quartiles 3.0 and 13.5) and the mean RNFL-thickness global was 65.9 µm (SD ± 16.1). Median MPOD measured at 0.51°, 1.02° and 1.99° retinal eccentricity in the glaucoma group was 0.42 DU, 0.34 DU and 0.13 DU, in the control group 0.40 DU, 0.35 DU and 0.12 DU respectively. There was no statistically significant difference of median MPOD between glaucomatous and control eyes (p=0.510, 0.735, 0.481). No significant relation between MPOD at 1.02 retinal eccentricity and the presence of glare symptoms was found (p=0.948). However, age seems to correlate with median MPOD measured at 1.02 retinal eccentricity (p=0.017). CONCLUSION: There was no evidence for lower MPOD levels in our glaucoma patients; lower MPOD was not related to the presence of glare symptoms. However there seems to be a positive correlation between age and MPOD at 1.02° retinal eccentricity. To further investigate the relation between glare reported by glaucoma patients and glare disability linked to lower MPOD levels, additional studies are necessary that include both detailed inquiry of the quality of glare and a glare quantification and precise analysis of MPOD levels in glaucoma patients. Dove 2020-04-01 /pmc/articles/PMC7140904/ /pubmed/32308361 http://dx.doi.org/10.2147/OPTH.S224259 Text en © 2020 Bruns et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bruns, Yannick
Junker, Bernd
Boehringer, Daniel
Framme, Carsten
Pielen, Amelie
Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title_full Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title_fullStr Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title_full_unstemmed Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title_short Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects – A Prospective Diagnostic Study
title_sort comparison of macular pigment optical density in glaucoma patients and healthy subjects – a prospective diagnostic study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140904/
https://www.ncbi.nlm.nih.gov/pubmed/32308361
http://dx.doi.org/10.2147/OPTH.S224259
work_keys_str_mv AT brunsyannick comparisonofmacularpigmentopticaldensityinglaucomapatientsandhealthysubjectsaprospectivediagnosticstudy
AT junkerbernd comparisonofmacularpigmentopticaldensityinglaucomapatientsandhealthysubjectsaprospectivediagnosticstudy
AT boehringerdaniel comparisonofmacularpigmentopticaldensityinglaucomapatientsandhealthysubjectsaprospectivediagnosticstudy
AT frammecarsten comparisonofmacularpigmentopticaldensityinglaucomapatientsandhealthysubjectsaprospectivediagnosticstudy
AT pielenamelie comparisonofmacularpigmentopticaldensityinglaucomapatientsandhealthysubjectsaprospectivediagnosticstudy